DESCRIPTION
BPC-157 / TB-500 is a dual-component research peptide formulation supplied exclusively for controlled laboratory research environments. This lyophilized research blend is intended for non-clinical applications involving peptide characterization, analytical method development, and experimental evaluation in model systems. The combination is commonly utilized in laboratory research investigating peptide stability, extracellular matrix biology, cellular migration, and tissue regeneration pathways.
COMPOSITION
BPC-157: 10 mg
TB-500 (Thymosin Beta-4): 10 mg
Appearance: Lyophilized powder in a sealed research vial.
RESEARCH FOCUS (NON-CLINICAL)
Combined identity and purity assessment of BPC-157 and TB-500.
Analytical assay development and validation for dual-peptide formulations.
Chromatographic method optimization for separation and impurity profiling.
Stability characterization of the lyophilized peptide blend under laboratory storage conditions.
DOCUMENTATION
Lot-specific Certificate of Analysis (COA).
Batch and lot traceability.
QR code access to product documentation.
Manufacturing quality documentation.
IMPORTANT NOTICE
For research use only.
Not for human consumption.
Not intended for diagnostic, therapeutic, veterinary, or clinical use.
Not intended to diagnose, treat, cure, or prevent any disease.
QUALITY & MANUFACTURING
Manufactured in the USA in an ISO 9001-based, cGMP-aligned facility.
Third-party tested with lot-specific Certificate of Analysis (COA).
Lyophilized for laboratory stability and secure transit.
Tamper-evident seal with printed lot number and test date.
Each lot documented throughout production.
